Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,001,862
-
Total 13F shares
-
9,319,042
-
Share change
-
-906,912
-
Total reported value
-
$25,248,000
-
Price per share
-
$2.71
-
Number of holders
-
25
-
Value change
-
-$3,677,975
-
Number of buys
-
14
-
Number of sells
-
9
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q2 2016
As of 30 Jun 2016,
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,319,042 shares.
The largest 10 holders included
FMR LLC, EcoR1 Capital, LLC, Partner Fund Management, L.P., Clough Capital Partners L P, Boxer Capital, LLC, Minerva Advisors LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, Alethea Capital Management, LLC, and Birchview Capital, LP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.